Screener
PJP vs RFV
Invesco Pharmaceuticals ETF vs Invesco S&P MidCap 400 Pure Value ETF
Key differences
- RFV costs 0.22% less per year.
- Over the last 3 years, RFV has delivered higher annualized returns.
Side-by-side comparison
| PJP | RFV | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.35% |
| Fund size (AUM) | $334M | $313M |
| Since | 2005 | 2006 |
| Dividend yield | 1.01% | 1.88% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +40.6% | +24.6% |
| CAGR 3Y | +14.0% | +16.7% |
| CAGR 5Y | +7.8% | +9.8% |
| Sharpe 3Y | 0.69 | 0.67 |
| Volatility 1Y | 16.23% | 18.26% |
| Max drawdown | -33.95% | -52.24% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and RFV
Explore further